The better RFS with the PI3K pathway mutation was significant only for proximal tumors. »
01/18/17

Proof-of-principle insight into a PI3K/Akt- and MEK/Erk-independent resistant model. »
05/10/17

IC responses to anti-PD-1 antibodies occur in pts with BM. »
04/06/17

Differential expression between malignant and normal tissues. »
01/14/17

Exploratory modeling suggests metformin use may be protective in a certain subgroup of patients. »
03/18/17

Overexpression of ENDOD1 suppressed cell proliferation. »
05/22/17

Cosmesis was judged good/excellent in the majority of the cases. »
05/23/17

Retention of these introns may have been responsible for the lack of dystrophin expression. »
05/23/17

Underlying evidence unsatisfactory. »
05/02/17

QOL and psychological adjustment of long-term survivors was relatively good. »
03/06/17